A United States-based subsidiary of Cipla has initiated a recall of certain batches of its generic anti-cancer medication Nilotinib Capsules following a manufacturing issue, according to the U.S. Food and Drug Administration (USFDA).The recall, issued by Cipla USA Inc., involves more than 400 cartons of